Ag Novartis - Net Worth and Insider Trading

Ag Novartis Net Worth

The estimated net worth of Ag Novartis is at least $583 Million dollars as of 2024-05-01. Ag Novartis is the 10% Owner of Alnylam Pharmaceuticals Inc and owns about 4,051,002 shares of Alnylam Pharmaceuticals Inc (ALNY) stock worth over $583 Million. Details can be seen in Ag Novartis's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Ag Novartis has not made any transactions after 2012-09-20 and currently still holds the listed stock(s).

Transaction Summary of Ag Novartis

To

Ag Novartis Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ag Novartis owns 24 companies in total, including Cellular Biomedicine Group Inc (CBMG) , Poseida Therapeutics Inc (PSTX) , and Akouos Inc (AKUS) among others .

Click here to see the complete history of Ag Novartis’s form 4 insider trades.

Insider Ownership Summary of Ag Novartis

Ticker Comapny Transaction Date Type of Owner
CBMG Cellular Biomedicine Group Inc 2020-08-11 10 percent owner
PSTX Poseida Therapeutics Inc 2020-07-09 10 percent owner
AKUS Akouos Inc 2020-06-25 10 percent owner
FMTX Forma Therapeutics Holdings Inc 2020-06-18 10 percent owner
GRTX Galera Therapeutics Inc 2019-11-06 10 percent owner
BCYC Bicycle Therapeutics PLC 2019-05-22 10 percent owner
ARPO Aerpio Pharmaceuticals Inc 2019-04-25 10 percent owner
ALRN Aileron Therapeutics Inc 2017-06-28 10 percent owner
NTLA Intellia Therapeutics Inc 2018-12-31 10 percent owner
ALT Altimmune Inc 2017-05-04 10 percent owner
AVXS AveXis Inc 2018-05-15 10 percent owner
SYRE Spyre Therapeutics Inc 2016-04-06 10 percent owner
SURF Surface Oncology Inc 2018-04-18 10 percent owner
FIXX Homology Medicines Inc 2018-03-27 10 percent owner
RARX Ra Pharmaceuticals Inc 2017-06-16 10 percent owner
PTI Proteostasis Therapeutics Inc 2016-02-17 10 percent owner
ELDN Eledon Pharmaceuticals Inc 2014-09-16 10 percent owner
ALNY Alnylam Pharmaceuticals Inc 2012-09-20 10 percent owner
ATRX Adhera Therapeutics Inc 2010-07-21 10 percent owner
MNTA Momenta Pharmaceuticals Inc 2006-07-25 10 percent owner
AADI Aadi Bioscience Inc 2017-03-15 10 percent owner
YMTX Yumanity Therapeutics Inc 2016-02-10 10 percent owner
DTIL Precision BioSciences Inc 2022-06-15 10 percent owner
KA Kineta Inc 2016-02-10 10 percent owner

Ag Novartis Latest Holdings Summary

Ag Novartis currently owns a total of 1 stock. Ag Novartis owns 4,051,002 shares of Alnylam Pharmaceuticals Inc (ALNY) as of September 20, 2012, with a value of $583 Million.

Latest Holdings of Ag Novartis

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALNY Alnylam Pharmaceuticals Inc 2012-09-20 4,051,002 143.95 583,141,738

Holding Weightings of Ag Novartis


Ag Novartis Form 4 Trading Tracker

According to the SEC Form 4 filings, Ag Novartis has made a total of 0 transactions in Alnylam Pharmaceuticals Inc (ALNY) over the past 5 years. The most-recent trade in Alnylam Pharmaceuticals Inc is the sale of 1,551,896 shares on September 20, 2012, which brought Ag Novartis around $30 Million.

Insider Trading History of Ag Novartis

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ag Novartis Trading Performance

GuruFocus tracks the stock performance after each of Ag Novartis's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ag Novartis is 5.78%. GuruFocus also compares Ag Novartis's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ag Novartis within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Ag Novartis's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Ag Novartis

Average Return

-27.84%

Average return per transaction

Outperforming Transactions

0%

0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 7.57 5.78 -15.26 -27.84 -23.56 -3.31
Relative Return to S&P 500(%) 11.78 6.28 -22 -44.12 -36.9 -14.93

Ag Novartis Ownership Network

Ownership Network List of Ag Novartis

No Data

Ownership Network Relation of Ag Novartis


Ag Novartis Owned Company Details

What does Cellular Biomedicine Group Inc do?

Who are the key executives at Cellular Biomedicine Group Inc?

Ag Novartis is the 10 percent owner of Cellular Biomedicine Group Inc. Other key executives at Cellular Biomedicine Group Inc include 10 percent owner Pharma Ag Novartis , 10 percent owner Maplebrook Ltd , and 10 percent owner Sailing Capital Overseas Investments Fund, LP .

Cellular Biomedicine Group Inc (CBMG) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Cellular Biomedicine Group Inc (CBMG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cellular Biomedicine Group Inc (CBMG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cellular Biomedicine Group Inc (CBMG)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cellular Biomedicine Group Inc Insider Transactions

No Available Data

Ag Novartis Mailing Address

Above is the net worth, insider trading, and ownership report for Ag Novartis. You might contact Ag Novartis via mailing address: Lichtstrasse 35, Basel V8 Ch 4056.

Discussions on Ag Novartis

No discussions yet.